General Information of the Compound
| Compound ID |
CP0379249
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(4R,4aS,7S,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-7-(dimethylamino)isoquinoline-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H36N4O4
|
||||||||||||||||||
| Molecular Weight |
540.664
|
||||||||||||||||||
| Canonical SMILES |
CN(C)c1ccc2cc(ncc2c1)C(=O)N[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CC1)c45
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H36N4O4/c1-35(2)22-7-5-19-14-24(33-16-21(19)13-22)30(38)34-23-9-10-32(39)26-15-20-6-8-25(37)28-27(20)31(32,29(23)40-28)11-12-36(26)17-18-3-4-18/h5-8,13-14,16,18,23,26,29,37,39H,3-4,9-12,15,17H2,1-2H3,(H,34,38)/t23-,26+,29-,31-,32+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
RKYIVQNLDQEZRZ-VWUFSNCOSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01791, Delta-type opioid receptor
Protein ID: PT02264, Kappa-type opioid receptor
Protein ID: PT02699, Mu-type opioid receptor